|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.265 HKD | +3.92% |
|
+1.92% | +21.56% |
Tianda Pharmaceuticals Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was HKD 249.86 million compared to HKD 236.52 million a year ago. Net loss was HKD 16.35 million compared to HKD 17.95 million a year ago.
Basic loss per share from continuing operations was HKD 0.0076 compared to HKD 0.0083 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.56% | 70.04M | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
TIANDA PHARMACEUTICALS LIMITED 
